Abstract
Antithrombin (AT) is a naturally occurring plasma inhibitor of coagulation, which is a synthesized in the liver. AT inhibits coagulation serine proteases (the enzymatically activated forms of the clotting factors), mainly thrombin (factor IIa) and factor Xa, but also to a lesser extent factors IXa, XIa, and XIIa. Acting alone, AT inhibits coagulation factors, but does this very slowly; however, when coupled with heparin as a cofactor, the speed of inhibition is increased many fold. The AT/Heparin complex is the most powerful naturally occurring anticoagulant in blood. AT levels of <70% of normal can cause significant thrombosis. Low levels of AT are caused by inherited genetic defects or acquired causes from other disease states. Plasma AT levels can be determined using a chromogenic assay with either bovine thrombin or human factor Xa as the enzyme. The generated color generated in the assay is inversely proportional to the concentration of AT in the plasma.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Cooper PC, Coath F, Daly ME, Makris M (2011) The phenotypic and genetic assessment of antithrombin deficiency. Int J Lab Hematol 33:227–237
Baglin T, Gray E, Greaves M, Hunt BJ, Keeling D, Machin S, Mackie I, Makris M, Nokes T, Perry D, Tait RC, Walker I, Watson H (2010) Clinical guidelines for testing for heritable thrombophilia. Br J Haematol 149:209–215
Marlar RA, Gausman JN (2014) Laboratory testing issues for protein C, protein S, and antithrombin. Int J Lab Hematol 36:289–295
Cooper PC, Goodeve AC, Beauchamp NJ (2013) Quality in molecular biology testing for inherited thrombophilia disorders. Semin Thromb Hemost 38:600–612
Harper PL, Daly M, Price J, Edgar PF, Carrell RW (1991) Screening for heparin binding variants of antithrombin. J Clin Pathol 44:477–479
Kristensen SR, Rasmussen B, Pedersen S, Bathum L (2007) Detecting antithrombin deficiency may be a difficult task–more than one test is necessary. J Thromb Haemost 5:617–618
CLSI (2008) Collection, transport and processing of blood specimens for testing plasma based coagulation assays and molecular hemostasis assays: approved guideline, 5th edn. CLSI, Wayne, PA. H21–A5
Tran TH, Duckert F (1985) Influence of heparin cofactor II (HCII) on the determination of antithrombin III (AT). Thromb Res 40:571–580
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Science+Business Media LLC
About this protocol
Cite this protocol
Gausman, J.N., Marlar, R.A. (2017). Assessment of Hereditary Thrombophilia: Performance of Antithrombin (AT) Testing. In: Favaloro, E., Lippi, G. (eds) Hemostasis and Thrombosis. Methods in Molecular Biology, vol 1646. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-7196-1_13
Download citation
DOI: https://doi.org/10.1007/978-1-4939-7196-1_13
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-7194-7
Online ISBN: 978-1-4939-7196-1
eBook Packages: Springer Protocols